Assessing the Use of Mobile Technology in Adult Asthma Patients

NCT03103880 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2024-07-30

No results posted yet for this study

Summary

This is a prospective, remote observational study of adults with persistent asthma who are managed on inhaled corticosteroids.

Conditions

Interventions

DEVICE

BreatheSmart

BreatheSmart is a comprehensive asthma monitoring system that combines a medical device and mobile application that are designed for use with Apple and Android mobile devices. The medical device connects to the mobile application using Bluetooth to facilitate the collection of controlled medication adherence, rescue medication usage, and asthma control.

Sponsors & Collaborators

  • CoheroHealth

    lead INDUSTRY

Principal Investigators

  • Anne Tam, MPH · Cohero Health, Inc.

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-21
Primary Completion
2018-08-29
Completion
2018-08-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03103880 on ClinicalTrials.gov